Clinical Trial Update: Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclophosphamide with or without celecoxib in recurrent/persistent ovarian epithelial, fallopian tube, or primary peritoneal cancer; tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Epithelial Cancer
• Peritoneal Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Celecoxib (Celecoxib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Fallopian Tube Cancer, Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-04-21